New insights into mechanisms of therapeutic effects of antimalarial agents in SLE

Response to Antimalarial Agents in Cutaneous Lupus Erythematosus

(2011) Aileen Y. Chang   ARCHIVES OF DERMATOLOGY

Impact of Smoking in Cutaneous Lupus Erythematosus

(2011) Evan W. Piette   ARCHIVES OF DERMATOLOGY

Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers

(2011) Reza Ehsanian et al.   Cell Communication and Signaling

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

(2011) E. Villanueva et al.   JOURNAL OF IMMUNOLOGY

Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines

(2011) A. Kuznik et al.   JOURNAL OF IMMUNOLOGY

Clinical and Pharmacogenetic Influences on Response to Hydroxychloroquine in Discoid Lupus Erythematosus: A Retrospective Cohort Study

(2011) Shyamal Wahie et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Revised Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy

(2011) Michael F. Marmor et al.   OPHTHALMOLOGY

Netting Neutrophils Are Major Inducers of Type I IFN Production in Pediatric Systemic Lupus Erythematosus

(2011) G. S. Garcia-Romo et al.   Science Translational Medicine

The type I interferon system in the development of lupus

(2011) Lars Rönnblom et al.   SEMINARS IN IMMUNOLOGY

A Toll-like receptor 9-mediated pathway stimulates perilipin 3 (TIP47) expression and induces lipid accumulation in macrophages

(2010) Jian-Qiu Gu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

(2010) P. M. Izmirly et al.   ANNALS OF THE RHEUMATIC DISEASES

Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort

(2010) Samuel K. Shinjo et al.   ARTHRITIS AND RHEUMATISM

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

Advances in drug therapy for systemic lupus erythematosus

(2010) Daniel J Wallace   BMC Medicine

Intracellular Toll-like Receptors

(2010) Amanda L. Blasius et al.   IMMUNITY

Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus

(2010) A. Lesiak et al.   LUPUS

DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs

(2010) C. Knox et al.   NUCLEIC ACIDS RESEARCH

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort

(2010) Guillermo J. Pons-Estel et al.   ARTHRITIS CARE & RESEARCH

Hydroxychloroquine treatment in a community-based cohort of patients with systemic lupus erythematosus

(2010) Gabriela Schmajuk et al.   ARTHRITIS CARE & RESEARCH

Cross-sectional Analysis of a Collaborative Web-Based Database for Lupus Erythematosus–Associated Skin Lesions

(2009) Siamak Moghadam-Kia et al.   ARCHIVES OF DERMATOLOGY

Lupus Erythematosus Tumidus

(2009) Alexander Kreuter et al.   ARCHIVES OF DERMATOLOGY

Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies

(2009) Maria G. Tektonidou et al.   ARTHRITIS AND RHEUMATISM

Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

(2009) Guillermo J. Pons-Estel et al.   ARTHRITIS AND RHEUMATISM

Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug

(2009) J. H. Rand et al.   BLOOD

New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents

(2009) Katerina Gurova   Future Oncology

Cigarette Smoking and Cutaneous Damage in Systemic Lupus Erythematosus

(2009) I. TURCHIN et al.   JOURNAL OF RHEUMATOLOGY

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

(2009) John Collinge et al.   LANCET NEUROLOGY

Treatment of lupus skin involvement with quinacrine and hydroxychloroquine

(2009) I Cavazzana et al.   LUPUS

Predictors of major infections in systemic lupus erythematosus

(2009) Guillermo Ruiz-Irastorza et al.   ARTHRITIS RESEARCH & THERAPY

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort

(2008) R Kaiser et al.   ANNALS OF THE RHEUMATIC DISEASES

Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis

(2008) A. Lesiak et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Previous antimalarial therapy in patients diagnosed with lupus nephritis: Influence on outcomes and survival

(2008) A Sisó et al.   LUPUS

The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor

(2008) Sarah E. Ewald et al.   NATURE